Robert Dimatteo News Today

For nearly 40 years, drugmakers have used genetically engineered cells as tiny drug factories. Such cells can be programmed to secrete compounds that yield drugs used to treat cancer and autoimmune conditions such as arthritis.Efforts to develop and

Drugmakers have been using genetically modified cells as small drug factories for over 40 years. These cells can be instructed to produce chemicals that can be utilized to treat cancer and autoimmune diseases like arthritis.

The advance could have implications for drug development and biological research.

For nearly 40 years, drugmakers have used genetically engineered cells as tiny drug factories. Such cells can be programmed to secrete compounds that yield drugs used to treat cancer and autoimmune conditions such as arthritis.

Di Carlo Lab/UCLA California NanoSystems Institute Bowl-shaped microparticles can be useful for capturing and analyzing individual cells or cell

Research brief: UCLA scientists were able to produce nanoliter-sized droplets at a rate 10 time faster than the current standard.